DuBiotech enlists RTI to help draw up standards
RTI will help Dubai Biotechnology and Research Park devise scientific and regulatory standards for biotechnology activity in the park.
The Dubai Biotechnology and Research Park (DuBiotech) has enlisted RTI International to help it devise scientific and regulatory standards for biotechnology activity in the park. RTI will help DuBiotech establish laboratory and operational standards adapted to the needs of Dubai and DuBiotech.
The framework will address general park regulations, health and safety issues, laboratory accreditation, environment and waste management, bioethics, clinical trials, non-clinical research and intellectual property. Working together, DuBiotech and RTI will also ensure that the recommended legal and regulatory framework complies with both UAE and Islamic laws and customs.
“Biotechnology opens a whole new world of economic and social possibility for the region,” said Dr. Abdulqader Al Khayat, executive director of DuBiotech. “A sound regulatory framework is necessary to harness biotechnology’s potential to improve health, enhance quality of life, support the environment and promote a sustainable economy. The regulations will provide a secure and encouraging environment for research and innovation, which is central to the growth of biotechnology,” he added.
DuBiotech, announced in February 2005, is a science and business park, with free zone status, dedicated to the biotech industry. It will feature a Foundation for Research and Innovation (FRI), which will focus on government funded R&D, and a dedicated industry cluster for biotech and related companies.
Al Khayat said that DuBiotech is keen to develop a framework based on international best practices, which is why RTI International was chosen as a consultant for the project. RTI is a non-profit research organisation that offers research and advice in the areas of healthcare, social development and the environment.
It works with the various US government agencies, including the Environmental Protection Agency, Food and Drug Administration, and National Institutes.
“We’re excited to be helping an organisation like DuBiotech set the stage for world-class research and development,” said Adam Saffer, Ph.D., executive vice president of strategic planning at RTI. “As the founding tenant of Research Triangle Park, we’re looking forward to the opportunity to share our knowledge and expertise to help establish DuBiotech as one of the leading research and development zones in the Middle East.”